BRIEF—Klue expands AI platform with diabetes offering

US digital health company Klue has announced its platform’s expansion into the type 1 diabetes (T1D) sector.

Klue is already known for its gesture sensing and analytics technology that promotes mindful eating and proper hydration, and now it is ready to branch out in diabetes.

Leveraging patented technology to create never-seen-before capabilities in the realm of treating T1D, Klue’s software unlocks solutions that will be life-changing for patients who have had a lifetime of daily injections and blood sugar monitoring.

Intuitive and proactive, Klue’s fine motor artificial intelligence technology detects high impact moments and allows individuals to better manage their health, all based on insights that are captured automatically and non-intrusively from analyzing their wrist movements.

Klue invites companies, researchers and developers in the T1D space to make use of its groundbreaking autonomous meal detection capabilities and unique insights into user eating behaviors to roll out new, innovative solutions.

Its platform APIs allow seamless integration with third-party applications and platforms, the company claims.